FGL2 and metabolic dysfunction-associated steatohepatitis: We found that fgl2 interacted with TLR4 on macrophages and regulated inflammatory signaling pathways and the Nod-like receptor protein 3 (NLRP3) inflammasome, leading to liver damage and lipid metabolism disorders in the progression of NASH.